GLP-1 RAs mimic a hormone your body naturally ... risk of gallstones due to rapid weight loss Rare concerns about thyroid cancer (though large studies have shown conflicting results and no ...

it has found no evidence that GLP-1 agonist drugs such as Novo Nordisk’s Ozempic and Eli Lilly’s Trulicity can cause cancer of the thyroid. Six months ago, the Pharmacovigilance Risk ...

The following is a summary of “Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists,” ...

Stanford Medicine researchers have identified a promising, naturally occurring molecule that could help people lose ...

GLP-1 medications like Ozempic have shown promise as treatment for symptoms caused by Polycystic Ovary Syndrome (PCOS). I ...

Regular follow-ups can also help doctors monitor signs of hypoglycemia, renal disease, pancreatitis and thyroid cancer. GLP-1 agonists are medications that primarily treat type 2 diabetes and obesity.

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Adding GLP-1s to progestin therapy appeared to ...

No significant difference was seen in the risk for any other hematologic cancer. GLP-1 RA use was associated with significantly lower risks for myeloid leukemia, lymphoid leukemia, non-Hodgkin ...

Kidney transplant recipients with type 2 diabetes treated with a new class of anti-obesity drugs were less likely to experience organ failure and survived longer, a new study shows. Not only ...

Could a diabetes drug slash your cancer risk? New research shows GLP-1 receptor agonists may protect patients with type 2 diabetes from deadly blood cancers—beyond just managing blood sugar.

One study reported that the incidence of thyroid cancer in semaglutide-treated patients was less than 1%. As of now, the FDA warning stands. So if you do have a family or personal history of MTC ...